Science (New York, N.Y.)HumansAntimalarialsClinical Trials as TopicDrug ResistanceMalaria
'A sigh of relief': New malaria drug succeeds in clinical trial as existing treatments falter.
Kai Kupferschmidt
Published: 202510.1126/science.aee0352
Abstract
Ganaplacide, developed by Novartis, eases worries about drug resistance-but hard choices loom on how to use it.